137 related articles for article (PubMed ID: 4058078)
1. Sequential treatment of metastatic breast cancer with tamoxifen after megestrol acetate therapy and vice versa (a retrospective study).
Alexieva-Figusch J; Van Putten WL; van Gilse HA; Blonk-vd Wijst J; Klijn JG
Med Oncol Tumor Pharmacother; 1985; 2(2):69-75. PubMed ID: 4058078
[TBL] [Abstract][Full Text] [Related]
2. Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer.
Gill PG; Gebski V; Snyder R; Burns I; Levi J; Byrne M; Coates A
Ann Oncol; 1993 Nov; 4(9):741-4. PubMed ID: 8280654
[TBL] [Abstract][Full Text] [Related]
3. Comparison of antiestrogen and progestogen therapy for initial treatment and consequences of their combination for second-line treatment of recurrent breast cancer.
Paterson AH; Hanson J; Pritchard KI; Sansregret E; Dahrouge S; McDermot RS; Fine S; White DF; Trudeau M; Stewart DJ
Semin Oncol; 1990 Dec; 17(6 Suppl 9):52-62. PubMed ID: 2259927
[TBL] [Abstract][Full Text] [Related]
4. Megestrol acetate: first-line therapy for advanced breast cancer.
Johnson PA; Bonomi PD; Anderson KM; Wolter JM; Economou SG
Semin Oncol; 1986 Dec; 13(4 Suppl 4):15-9. PubMed ID: 3798124
[TBL] [Abstract][Full Text] [Related]
5. Megestrol acetate: phase II study of a single daily administration in advanced breast cancer.
Pronzato P; Brema F; Amoroso D; Bertelli G; Conte PF; Martini MC; Pastorino G; Rosso R
Breast Cancer Res Treat; 1990 Nov; 17(1):51-4. PubMed ID: 2095927
[TBL] [Abstract][Full Text] [Related]
6. Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients.
Morgan LR
Semin Oncol; 1985 Mar; 12(1 Suppl 1):43-7. PubMed ID: 3975652
[TBL] [Abstract][Full Text] [Related]
7. Treatment of advanced breast cancer with megestrol acetate after therapy with tamoxifen.
Ross MB; Buzdar AU; Blumenschein GR
Cancer; 1982 Feb; 49(3):413-7. PubMed ID: 6174195
[TBL] [Abstract][Full Text] [Related]
8. Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.
Muss HB; Wells HB; Paschold EH; Black WR; Cooper MR; Capizzi RL; Christian R; Cruz JM; Jackson DV; Powell BL
J Clin Oncol; 1988 Jul; 6(7):1098-106. PubMed ID: 3292710
[TBL] [Abstract][Full Text] [Related]
9. Megestrol acetate in advanced breast carcinoma after failure to tamoxifen and/or aminoglutethimide.
Brufman G; Isacson R; Haim N; Gez E; Sulkes A
Oncology; 1994; 51(3):258-61. PubMed ID: 8196908
[TBL] [Abstract][Full Text] [Related]
10. Metastatic breast cancer: preliminary results with oral hormonal therapy.
Allegra JC; Bertino J; Bonomi P; Byrne P; Carpenter J; Catalano R; Creech R; Dana B; Durivage H; Einhorn L
Semin Oncol; 1985 Dec; 12(4 Suppl 6):61-4. PubMed ID: 3909420
[TBL] [Abstract][Full Text] [Related]
11. An overview of megestrol acetate for the treatment of advanced breast cancer.
Sedlacek SM
Semin Oncol; 1988 Apr; 15(2 Suppl 1):3-13. PubMed ID: 3285483
[TBL] [Abstract][Full Text] [Related]
12. Endocrine effects of the combination of megestrol acetate and tamoxifen in the treatment of metastatic breast cancer.
Alexieva-Figusch J; Blankenstein MA; de Jong FH; Lamberts SW
Eur J Cancer Clin Oncol; 1984 Sep; 20(9):135-40. PubMed ID: 6434315
[TBL] [Abstract][Full Text] [Related]
13. Megestrol acetate: clinical experience.
Schacter L; Rozencweig M; Canetta R; Kelley S; Nicaise C; Smaldone L
Cancer Treat Rev; 1989 Mar; 16(1):49-63. PubMed ID: 2471590
[TBL] [Abstract][Full Text] [Related]
14. Megestrol acetate plus alpha 2a interferon as second line therapy for postmenopausal patients with advanced breast cancer: results of a multicentric phase II trial.
Amoroso D; Boccardo F; Balestrero M; Miglietta L; Brema F; Cellerino R; Farris A; Folco U; Iacobelli S; Mesiti M
Breast Cancer Res Treat; 1995 Mar; 33(3):265-8. PubMed ID: 7749154
[TBL] [Abstract][Full Text] [Related]
15. Megestrol acetate: a new role in the treatment of metastatic breast cancer.
Allegra JC
Semin Hematol; 1987 Apr; 24(2 Suppl 1):45-7. PubMed ID: 3589707
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial of megestrol acetate with or without premarin in the treatment of potentially responsive metastatic breast cancer. A Study of the Eastern Cooperative Oncology Group (E2185).
Cobau CD; Declercq K; Neuberg D; Ingle JN; Tormey DC
Cancer; 1996 Feb; 77(3):483-9. PubMed ID: 8630955
[TBL] [Abstract][Full Text] [Related]
17. Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen.
Bonomi P; Gale M; Von Roenn J; Anderson K; Johnson P; Wolter J; Economou S
Semin Oncol; 1988 Apr; 15(2 Suppl 1):26-33. PubMed ID: 3368797
[TBL] [Abstract][Full Text] [Related]
18. Investigations on the nutritional status of advanced breast cancer patients. The influence of long-term treatment with megestrol acetate or tamoxifen.
Schrijver J; Alexieva-Figusch J; van Breederode N; van Gilse HA
Nutr Cancer; 1987; 10(4):231-45. PubMed ID: 3432093
[TBL] [Abstract][Full Text] [Related]
19. Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.
Buzdar A; Jonat W; Howell A; Jones SE; Blomqvist C; Vogel CL; Eiermann W; Wolter JM; Azab M; Webster A; Plourde PV
J Clin Oncol; 1996 Jul; 14(7):2000-11. PubMed ID: 8683230
[TBL] [Abstract][Full Text] [Related]
20. A randomised phase III cross-over study of tamoxifen versus megestrol acetate in advanced and recurrent breast cancer.
Stuart NS; Warwick J; Blackledge GR; Spooner D; Keen C; Taylor AR; Tyrell C; Webster DJ; Earl H
Eur J Cancer; 1996 Oct; 32A(11):1888-92. PubMed ID: 8943670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]